Login
$HCA
$511.78 +$0.00 (0.0%) After hours

$HCA SEC Filings

Filed On Filing
10 Nov 2026 Form 4: Rossitto Erica, SVP & Chief Nurse Executive

Received 13,120 shares by exercise or conversion ($1.17M) · Gave up 6,601 shares to cover exercise price or tax ($3.27M) · Sold 3,500 shares ($1.77M)

10 Nov 2026 144
06 Nov 2026 Form 4: Elcan Patricia F, 10% owner

Disposed of 886,871 shares (Other Transaction) ($447M) · Acquired 886,871 shares (Other Transaction) ($447M)

06 Nov 2026 Form 4: Frist Thomas F Iii, Director

Disposed of 555,500 shares (Other Transaction) ($280M) · Acquired 555,500 shares (Other Transaction) ($280M)

06 Nov 2026 SCHEDULE 13D/A
06 Nov 2026 Form 4: Schlosser Michael J, EVP and Chief Clinical Officer

Sold 1,200 shares ($594K)

06 Nov 2026 Form 4: Foster Jon M, EVP and COO

Sold 10,000 shares ($5.14M) · Received 35,880 shares by exercise or conversion ($5.21M) · Gave up 20,309 shares to cover exercise price or tax ($10.4M) · 2 more

05 Nov 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more

andDEUTSCHE BANK TRUST COMPANY AMERICAS,as Paying Agent, Registrar and Transfer Agent

04 Nov 2026 144
04 Nov 2026 144
04 Nov 2026 424B5
03 Nov 2026 Form 4: Marks Mike A, EVP and CFO

Received 4,585 shares by exercise or conversion ($376K) · Gave up 2,287 shares to cover exercise price or tax ($1.08M) · Disposed of 1,042 shares (Other Transaction) ($489K) · 1 more

03 Nov 2026 FWP
02 Nov 2026 Form 4: Schlosser Michael J, EVP and Chief Clinical Officer

Received 4,928 shares by exercise or conversion ($406K) · Gave up 2,455 shares to cover exercise price or tax ($1.17M) · Granted 2,797 Stock Appreciation Right

02 Nov 2026 8-K: Other Events

NASHVILLE, Tenn., November 2, 2026 – HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior note...

02 Nov 2026 424B3
29 Oct 2026 10-Q
29 Oct 2026 144
27 Oct 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more

Nashville, Tenn., October 27, 2026 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2026.

11 Sep 2026 Form 3: Schlosser Michael J, EVP and Chief Clinical Officer

Holds 170.1027 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support